HIV/AIDS Treatment Guidelines Search Results| NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 21 – 40 of 40

Microsporidiosis

Disseminated Mycobacterium avium Complex Disease

Mycobacterium tuberculosis Infection and Disease

Progressive Multifocal Leukoencephalopathy/JC Virus Infection

Pneumocystis Pneumonia

Talaromycosis (Formerly Penicilliosis)

Varicella-Zoster Virus Disease

Table 1. Chemoprophylaxis to Prevent First Episode of Opportunistic Disease

Table 2. Treatment of HIV-Associated Opportunistic Infections (Includes Recommendations for Acute Treatment and Secondary Prophylaxis/Chronic Suppressive/Maintenance Therapy)

Table 3. Indications for Discontinuing and Restarting Primary and Secondary Prophylaxis (or Chronic Maintenance Therapy) for Selected Opportunistic Infections in Adults and Adolescents with HIV

Table 4. Significant Pharmacokinetic Interactions Between Drugs Used to Treat or Prevent Opportunistic Infections

Table 5. Serious and/or Common Adverse Reactions Associated with Systemically Administered Drugs Used to Treat or Prevent Opportunistic Infections

Table 6. Dosing Recommendations for Drugs Used to Treat or Prevent Opportunistic Infections that Require Dosage Adjustment in Adults With Renal Insufficiency

Appendix A: List of Abbreviations

Appendix B: Panel Roster and Financial Disclosures